These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6154986)

  • 21. Protection from chlordecone-amplified carbon tetrachloride toxicity by cyanidanol: biochemical and histological studies.
    Soni MG; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):46-57. PubMed ID: 1706539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of adrenalectomy on chlordecone potentiation of carbontetrachloride hepatotoxicity.
    Agarwal AK; Mehendale HM
    Fundam Appl Toxicol; 1983; 3(6):507-11. PubMed ID: 6198234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excessive hepatic accumulation of intracellular Ca2+ in chlordecone potentiated CCl4 toxicity.
    Agarwal AK; Mehendale HM
    Toxicology; 1984 Feb; 30(1):17-24. PubMed ID: 6199871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of chlordecone-potentiated carbon tetrachloride hepatotoxicity and lethality by partial hepatectomy.
    Bell AN; Young RA; Lockard VG; Mehendale HM
    Arch Toxicol; 1988 Apr; 61(5):392-405. PubMed ID: 2456051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity: a light and electron microscopic study.
    Lockard VG; Mehendale HM; O'Neal RM
    Exp Mol Pathol; 1983 Oct; 39(2):230-45. PubMed ID: 6194012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity: a morphometric and biochemical study.
    Lockard VG; Mehendale HM; O'Neal RM
    Exp Mol Pathol; 1983 Oct; 39(2):246-55. PubMed ID: 6194013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute hepatotoxicity and lethality of CCl4 in chlordecone-pretreated rats.
    Klingensmith JS; Lockard V; Mehendale HM
    Exp Mol Pathol; 1983 Aug; 39(1):1-10. PubMed ID: 6192011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlordecone-induced hepatic dysfunction.
    Mehendale HM
    J Toxicol Environ Health; 1981; 8(5-6):743-55. PubMed ID: 6175767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlordecone potentiates hepatic fibrosis in chronic liver injury induced by carbon tetrachloride in mice.
    Tabet E; Genet V; Tiaho F; Lucas-Clerc C; Gelu-Simeon M; Piquet-Pellorce C; Samson M
    Toxicol Lett; 2016 Jul; 255():1-10. PubMed ID: 26853152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal relationships between biotransformation, detoxication, and chlordecone potentiation of chloroform-induced hepatotoxicity.
    Hewitt LA; Caillé G; Plaa GL
    Can J Physiol Pharmacol; 1986 Apr; 64(4):477-82. PubMed ID: 2425914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perturbations in polyamines and related enzymes following chlordecone-potentiated bromotrichloromethane hepatotoxicity.
    Rao SB; Young RA; Mehendale HM
    J Biochem Toxicol; 1990; 5(1):23-32. PubMed ID: 1698228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlordecone potentiation of CCl4 hepatotoxicity in ovariectomized rats.
    Agarwal AK; Mehendale HM
    Toxicology; 1984 Feb; 29(4):315-23. PubMed ID: 6199870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of calcium homeostasis leads to progressive phase of chlordecone-potentiated carbon tetrachloride hepatotoxicity.
    Kodavanti PR; Rao VC; Mehendale HM
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):77-87. PubMed ID: 7690997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic failure leads to lethality of chlordecone-amplified hepatotoxicity of carbon tetrachloride.
    Soni MG; Mehendale HM
    Fundam Appl Toxicol; 1993 Nov; 21(4):442-50. PubMed ID: 7504640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resiliency to amplification of carbon tetrachloride hepatotoxicity by chlordecone during postnatal development in rats.
    Cai Z; Mehendale HM
    Pediatr Res; 1993 Mar; 33(3):225-32. PubMed ID: 7681558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related susceptibility to chlordecone-potentiated carbon tetrachloride hepatotoxicity and lethality is due to hepatic quiescence.
    Dalu A; Warbritton A; Bucci TJ; Mehendale HM
    Pediatr Res; 1995 Aug; 38(2):140-8. PubMed ID: 7478807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity.
    Curtis LR; Mehendale HM
    Drug Metab Dispos; 1980; 8(1):23-7. PubMed ID: 6153597
    [No Abstract]   [Full Text] [Related]  

  • 38. Carbon tetrachloride-induced alterations of hepatic calmodulin and free calcium levels in rats pretreated with chlordecone.
    Kodavanti PR; Kodavanti UP; Mehendale HM
    Hepatology; 1991 Feb; 13(2):230-8. PubMed ID: 1704867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatotoxicity and lethality of halomethanes in Mongolian gerbils pretreated with chlordecone, phenobarbital or mirex.
    Cai Z; Mehendale HM
    Arch Toxicol; 1991; 65(3):204-12. PubMed ID: 1711308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic polyamines and related enzymes following chlordecone-potentiated carbon tetrachloride toxicity in rats.
    Rao SB; Young RA; Mehendale HM
    J Biochem Toxicol; 1989; 4(1):55-63. PubMed ID: 2475629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.